Literature DB >> 688083

The rabbit mesenteric vein: a specific bioassay for substance P.

A Bérubé, F Marceau, J N Drouin, F Rioux, D Regoli.   

Abstract

The anterior mesenteric vein of the rabbit responds to substance P with dose-dependent contractions and is among the vascular smooth muscles most sensitive to this peptide. In spite of its high sensitivity to numerous other agents, including angiotensin and bradykinin, the rabbit mesenteric vein can be made selective for substance P by the use of specific inhibitors that will prevent the myotropic effects of acetylcholine, catecholamines, histamine, 5-hydroxytryptamine, and of the two above-mentioned peptides, without modifying the contractions elicited by substance P. It appears that this peptide acts directly on specific receptors and not through the release of neurotransmitters. Interference by intramural prostaglandins is excluded because substance P is equally active on tissues pretreated with indomethacin or untreated. Dose-response curves obtained with substance P are close to the theoretical curves predicted by the mass action law. The rabbit mesenteric vein contains a new type of receptor for bradykinin, recently identified (REGOLI, D., MARCEAU, F., and BARABE, J. 1978. De novo formation of vascular receptors for bradykinin. Can, J. Physiol. Pharmacol. 56, in press.). The action of bradykinin on this receptor can be prevented with the use of specific and competitive inhibitors and, therefore, the mesenteric vein will distinguish between peptides of the kinins or of the substance P types.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 688083     DOI: 10.1139/y78-096

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  4 in total

1.  Substance P-containing nerve fibres in large peripheral blood vessels of the rat.

Authors:  F Barja; R Mathison; H Huggel
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

2.  Smooth muscle of rabbit isolated aorta contains the NK-2 tachykinin receptor.

Authors:  J W Constantine; W S Lebel; H A Woody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

3.  Structure-activity studies on bradykinin and related peptides: agonists.

Authors:  N E Rhaleb; G Drapeau; S Dion; D Jukic; N Rouissi; D Regoli
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

4.  Effects of endorphins on different parts of the gastrointestinal tract of rat and guinea-pig in vitro.

Authors:  F P Nijkamp; J M Van Ree
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.